Men with metastatic castration-resistant prostate cancer should be treated primarily with second-generation hormone drugs, which offer better treatment response and longer life expectancy than chemotherapy.
Precision medicine enhances prostate cancer treatment with genetic profiling
- Post author:
- Post published:August 20, 2024
- Post category:uncategorized